Tsuno T - Search Results

1

Inhibition of Aurora-B function increases formation of multinucleated cells in p53 gene deficient cells and enhances anti-tumor effect of temozolomide in human glioma cells.

Tsuno T, Natsume A, Katsumata S, Mizuno M, Fujita M, Osawa H, Nakahara N, Wakabayashi T, Satoh Y, Inagaki M, Yoshida J. Tsuno T, et al. J Neurooncol. 2007 Jul;83(3):249-58. doi: 10.1007/s11060-007-9335-1. Epub 2007 Feb 14. J Neurooncol. 2007. PMID: 17570035

2

Vaccination with tumor cell lysate-pulsed dendritic cells augments the effect of IFN-beta gene therapy for malignant glioma in an experimental mouse intracranial glioma.

Saito R, Mizuno M, Nakahara N, Tsuno T, Kumabe T, Yoshimoto T, Yoshida J. Saito R, et al. Among authors: tsuno t. Int J Cancer. 2004 Sep 20;111(5):777-82. doi: 10.1002/ijc.20331. Int J Cancer. 2004. PMID: 15252850

3

IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide.

Natsume A, Ishii D, Wakabayashi T, Tsuno T, Hatano H, Mizuno M, Yoshida J. Natsume A, et al. Among authors: tsuno t. Cancer Res. 2005 Sep 1;65(17):7573-9. doi: 10.1158/0008-5472.CAN-05-0036. Cancer Res. 2005. PMID: 16140920

4

Susceptibility to exogenously added interferon-beta protein depends on intracellular interferon-beta mRNA level in human glioma cells.

Osawa H, Mizuno M, Hatano M, Nakahara N, Tsuno T, Kuno T, Endo M, Yoshida J. Osawa H, et al. Among authors: tsuno t. Cytokine. 2005 Dec 7;32(5):240-5. doi: 10.1016/j.cyto.2005.10.003. Epub 2005 Dec 15. Cytokine. 2005. PMID: 16343929

5

Growth inhibition of human pancreatic cancer cells by human interferon-beta gene combined with gemcitabine.

Endou M, Mizuno M, Nagata T, Tsukada K, Nakahara N, Tsuno T, Osawa H, Kuno T, Fujita M, Hatano M, Yoshida J. Endou M, et al. Among authors: tsuno t. Int J Mol Med. 2005 Feb;15(2):277-83. Int J Mol Med. 2005. PMID: 15647844

6

A novel role for IFN-stimulated gene factor 3II in IFN-γ signaling and induction of antiviral activity in human cells.

Morrow AN, Schmeisser H, Tsuno T, Zoon KC. Morrow AN, et al. Among authors: tsuno t. J Immunol. 2011 Feb 1;186(3):1685-93. doi: 10.4049/jimmunol.1001359. Epub 2010 Dec 22. J Immunol. 2011. PMID: 21178011 Free PMC article.

7

IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.

Tsuno T, Mejido J, Zhao T, Schmeisser H, Morrow A, Zoon KC. Tsuno T, et al. J Immunother. 2009 Oct;32(8):803-16. doi: 10.1097/CJI.0b013e3181ad4092. J Immunother. 2009. PMID: 19752753 Free PMC article.

8

BID is a critical factor controlling cell viability regulated by IFN-α.

Tsuno T, Mejido J, Zhao T, Phillips T, Myers TG, Bekisz J, Zoon KC. Tsuno T, et al. J Immunother. 2012 Jan;35(1):23-31. doi: 10.1097/CJI.0b013e3182372dcf. J Immunother. 2012. PMID: 22130162 Free PMC article.

9

Intracranial meningeal melanocytoma diagnosed using an interdisciplinary approach: a case report and review of the literature.

Gamoh S, Tsuno T, Akiyama H, Kotaki S, Nakanishi T, Tsuji K, Yoshida H, Shimizutani K. Gamoh S, et al. Among authors: tsuno t. J Med Case Rep. 2018 Jun 26;12(1):177. doi: 10.1186/s13256-018-1725-9. J Med Case Rep. 2018. PMID: 29941032 Free PMC article. Review.

10

Safety and Efficacy of Intravenous Low-Dose Alteplase in Relative Contraindication Patients with Acute Ischemic Stroke.

Ohta T, Okada K, Fukuda M, Masahira N, Matsuoka T, Tsuno T, Takemura M. Ohta T, et al. Among authors: tsuno t. J Stroke Cerebrovasc Dis. 2018 Jul;27(7):1844-1851. doi: 10.1016/j.jstrokecerebrovasdis.2018.02.026. Epub 2018 Mar 16. J Stroke Cerebrovasc Dis. 2018. PMID: 29555402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters